Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $104.0500 (-1.28%) ($103.7200 - $106.1300) on Wed. Feb. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.41% (three month average) | RSI | 34 | Latest Price | $104.0500(-1.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.5% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(44%) SPLV(36%) VYM(32%) XLP(32%) DIA(31%) | Factors Impacting ABBV price | ABBV will decline at least -0.705% in a week (0% probabilities). VIXM(-22%) UUP(-9%) VXX(-3%) IGOV(-2%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.705% (StdDev 1.41%) | Hourly BBV | -1.5 () | Intraday Trend | -1.8% | | | |
|
Resistance Level | $107.67 | 5 Day Moving Average | $106.71(-2.49%) | 10 Day Moving Average | $105.36(-1.24%) | 20 Day Moving Average | $107.67(-3.36%) | To recent high | -7.6% | To recent low | 6.6% | Market Cap | $183.574b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |